RATIONALE: Numerous neuroimaging studies have demonstrated lower neural tissue density in chronic cocaine users, which may be linked to cognitive dysfunction. OBJECTIVES: The goal of this study was to determine whether neural tissue density was also impaired in individuals abstinent from cocaine and whether any observed changes were associated with cognitive performance. METHODS: A total of 73 participants were included: 24 active cocaine users, 24 abstainers (abstinent for at least 1 month), and 25 nondrug-abusing controls rigorously matched for age, gender, and IQ. All participants performed a cognitive assessment battery and received an MRI which was analyzed using voxel-based morphometry. RESULTS: The abstainers had significantly higher gray matter density than the current cocaine users in neocortical areas including the frontal and temporal cortex. In contrast to the users, there was no difference in white matter density in the abstainers relative to the controls. The abstainers performed better than current users on several behavioral tasks. Within users and abstainers, cortical density was correlated with performance on memory and reaction time tasks. Subcortical gray matter density was lower in both the users and abstainers relative to the controls. Within abstainers, subcortical tissue density was correlated with the ability to set-shift. CONCLUSIONS: These data suggest that individuals able to remain abstinent from cocaine for at least 1 month have elevated neocortical tissue density and perform better on multiple cognitive tests, relative to current cocaine users. Larger, longitudinal studies are needed to address this interaction between abstinence, cognition, and cortical tissue density directly.
RATIONALE: Numerous neuroimaging studies have demonstrated lower neural tissue density in chronic cocaine users, which may be linked to cognitive dysfunction. OBJECTIVES: The goal of this study was to determine whether neural tissue density was also impaired in individuals abstinent from cocaine and whether any observed changes were associated with cognitive performance. METHODS: A total of 73 participants were included: 24 active cocaine users, 24 abstainers (abstinent for at least 1 month), and 25 nondrug-abusing controls rigorously matched for age, gender, and IQ. All participants performed a cognitive assessment battery and received an MRI which was analyzed using voxel-based morphometry. RESULTS: The abstainers had significantly higher gray matter density than the current cocaine users in neocortical areas including the frontal and temporal cortex. In contrast to the users, there was no difference in white matter density in the abstainers relative to the controls. The abstainers performed better than current users on several behavioral tasks. Within users and abstainers, cortical density was correlated with performance on memory and reaction time tasks. Subcortical gray matter density was lower in both the users and abstainers relative to the controls. Within abstainers, subcortical tissue density was correlated with the ability to set-shift. CONCLUSIONS: These data suggest that individuals able to remain abstinent from cocaine for at least 1 month have elevated neocortical tissue density and perform better on multiple cognitive tests, relative to current cocaine users. Larger, longitudinal studies are needed to address this interaction between abstinence, cognition, and cortical tissue density directly.
Authors: M M A Nielen; D J Heslenfeld; K Heinen; J W Van Strien; M P Witter; C Jonker; D J Veltman Journal: Brain Cogn Date: 2009-08-08 Impact factor: 2.310
Authors: N D Volkow; L Chang; G J Wang; J S Fowler; D Franceschi; M Sedler; S J Gatley; E Miller; R Hitzemann; Y S Ding; J Logan Journal: J Neurosci Date: 2001-12-01 Impact factor: 6.167
Authors: Teresa R Franklin; Paul D Acton; Joseph A Maldjian; Jason D Gray; Jason R Croft; Charles A Dackis; Charles P O'Brien; Anna Rose Childress Journal: Biol Psychiatry Date: 2002-01-15 Impact factor: 13.382
Authors: Igor Elman; Katherine H Karlsgodt; David R Gastfriend; Christopher F Chabris; Hans C Breiter Journal: J Psychopharmacol Date: 2002-06 Impact factor: 4.153
Authors: Thomas J R Beveridge; Hilary R Smith; Susan H Nader; Michael A Nader; Linda J Porrino Journal: Neuropharmacology Date: 2014-06-19 Impact factor: 5.250
Authors: Hilary R Smith; Thomas J R Beveridge; Susan H Nader; Michael A Nader; Linda J Porrino Journal: Brain Struct Funct Date: 2019-02-12 Impact factor: 3.270
Authors: Anderson Mon; Timothy C Durazzo; Christoph Abe; Stefan Gazdzinski; David Pennington; Thomas Schmidt; Dieter J Meyerhoff Journal: Drug Alcohol Depend Date: 2014-09-19 Impact factor: 4.492
Authors: Joy M Schmitz; Charles E Green; Khader M Hasan; Jessica Vincent; Robert Suchting; Michael F Weaver; F Gerard Moeller; Ponnada A Narayana; Kathryn A Cunningham; Kelly T Dineley; Scott D Lane Journal: Addiction Date: 2017-07-03 Impact factor: 6.526
Authors: Jaime S Ide; Sheng Zhang; Sien Hu; Rajita Sinha; Carolyn M Mazure; Chiang-Shan R Li Journal: Drug Alcohol Depend Date: 2013-09-17 Impact factor: 4.492
Authors: Kathleen M Kantak; Nicole Barlow; David H Tassin; Madeline F Brisotti; Chloe J Jordan Journal: Psychopharmacology (Berl) Date: 2014-05-07 Impact factor: 4.530